According to a new market research study of “Middle East and Africa Organoids Market Forecast to 2027 - Covid-19 Impact and Analysis by Type, Application, and Source,” Middle East and Africa organoids market is projected to reach US$ 141.26 million in 2027 from US$ 37.34 million in 2019; the market is estimated to grow at CAGR of 20.9% from 2020 to 2027. The report highlights trends prevailing in the Middle East and Africa organoids market and the factors driving market along with those that act as hindrances.
The organoids market, based on type, is segmented into stomach, intestine, liver, pancreas, lung, brain, kidney, and lung. In 2019, the intestine organoids segment accounted for the global organoids markets largest market share. The intestine organoids segment holds a significant market share in the organoids market due to rise in prevalence of inflammatory bowel diseases (IBD) across the globe. For instance, the inflammatory bowel disease (IBD) has affected 300 per 100,000 people across the world. Further, significant adoption of new technologies among researchers and academia; coupled with growing industry-academia collaborations for research, and technological advancements in 3D bioprinting will further offer lucrative opportunities in the review period. This research will involve use of conventional and high-throughput metagenomics, generation of intestinal organoids from murine and human subjects for identification of biomarkers of autoimmune diseases.
Middle East and Africa organoids market is expected to grow owing to growing research on organoids in Middle East and Africa region, and rising focus on developing alternatives for animal testing models. However, issues related to the incorporation of organoids into existing workflows is likely to have a negative impact on the growth of the market in the coming years.
Leading companies operating in the Middle East and Africa organoids market are Merck KGgA, Thermo Fisher Scientific, Corning Incorporated (Life Sciences), STEMCELL Technologies, Inc, PeproTech, Inc among others.
The report segments Middle East and Africa Organoids market as follows:
By Type
By Application
By Source
By Country
Reasons to Buy
The organoids market, based on type, is segmented into stomach, intestine, liver, pancreas, lung, brain, kidney, and lung. In 2019, the intestine organoids segment accounted for the global organoids markets largest market share. The intestine organoids segment holds a significant market share in the organoids market due to rise in prevalence of inflammatory bowel diseases (IBD) across the globe. For instance, the inflammatory bowel disease (IBD) has affected 300 per 100,000 people across the world. Further, significant adoption of new technologies among researchers and academia; coupled with growing industry-academia collaborations for research, and technological advancements in 3D bioprinting will further offer lucrative opportunities in the review period. This research will involve use of conventional and high-throughput metagenomics, generation of intestinal organoids from murine and human subjects for identification of biomarkers of autoimmune diseases.
Middle East and Africa organoids market is expected to grow owing to growing research on organoids in Middle East and Africa region, and rising focus on developing alternatives for animal testing models. However, issues related to the incorporation of organoids into existing workflows is likely to have a negative impact on the growth of the market in the coming years.
Leading companies operating in the Middle East and Africa organoids market are Merck KGgA, Thermo Fisher Scientific, Corning Incorporated (Life Sciences), STEMCELL Technologies, Inc, PeproTech, Inc among others.
The report segments Middle East and Africa Organoids market as follows:
By Type
- Stomach
- Intestine
- Liver
- Pancreas
- Lung
- Brain
- Kidney
- Others
By Application
- Developmental Biology
- Disease Pathology of Infectious Disease
- Regenerative Medicine
- Drug Toxicity and Efficacy Testing
- Drug Discovery and Personalized Medicine
- Others
By Source
- Pluripotent Stem Cells
- Organ-specific Adult Stem Cells
By Country
- Saudi Arabia
- UAE
- South Africa
- Rest of Middle East and Africa
Reasons to Buy
- To understand the Middle East and Africa organoids market landscape and identify market segments that are most likely to guarantee a strong return.
- Stay ahead of the race by comprehending the ever-changing competitive landscape for Middle East and Africa organoids market.
- Efficiently plan M&A and partnership deals in Middle East and Africa organoids market by identifying market segments with the most promising probable sales.
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Middle East and Africa organoids market.
- Obtain market revenue forecast for market by various segments from 2019-2027 in Middle East and Africa.
Table of Contents
1. Introduction
3. Research Methodology
4. Middle East and Africa Organoids Market Landscape
5. Middle East and Africa Organoids Market Key Market Dynamics
6. Organoids Market Analysis - By Type
7. Organoids Market Analysis - By Application
8. Organoids Market Analysis - By Source
9. Organoids Market Revenue and Forecasts To 2027 - Country Analysis
10. Impact of COVID-19 Pandemic on Global Organoids Market
11. Company Profiles
12. Appendix
List of Tables
List of Figures
Companies Mentioned
A selection of companies mentioned in this report includes:
- Merck KGgA
- Thermo Fisher Scientific
- Corning Incorporated (Life Sciences)
- STEMCELL Technologies, Inc
- PeproTech, Inc
